Recent Articles from Business Wire

Nu Holdings Ltd. (NYSE: NU) (“Nu” or the “Company”), one of the world’s largest digital banking platforms, announced that Eric Young, its Chief Technology Officer, has decided to resign to pursue a new professional opportunity. Mr. Young is expected to remain with the Company until November 12, 2026 to support an orderly transition.

KBRA assigns preliminary ratings to three classes of notes from US Signal Issuer LLC and US Signal Co-Issuer LLC Series 2026-1 and Series 2026-2 (together, Series 2026-1/2), a colocation data center ABS transaction. The transaction represents the first ABS issuance issued by US Signal Issuer LLC and US Signal Co-Issuer LLC. All series share in the same collateral pool.

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced it granted inducement equity awards to two newly-hired employees.

Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of investors who sold shares of Class A common stock of Skechers U.S.A., Inc. (formerly trading on NYSE: SKX) from April 24, 2025 through the closing of the take-private acquisition of Sketchers by 3G Capital Partners L.P. and its affiliates on September 12, 2025 (the "Class Period"). Skechers is a company that designs and markets footwear, apparel, and accessories in regional offices and showrooms globally.

Myers Industries, Inc. (NYSE: MYE) today announced that its Board of Directors has approved a quarterly cash dividend of $0.135 per share, payable on January 6, 2027, to shareholders of record as of December 4, 2026.

Independence in West Sacramento, a new gated community of 208 townhome-style rental homes developed by Lewis Apartments, will officially open its leasing office and model homes to the public on Saturday, October 24. The leasing office and models will be open daily from 9 a.m. to 6 p.m.

Summit Therapeutics Inc. (NASDAQ: SMMT) and Lunit Inc. (KRX: 328130) today announced a research agreement to evaluate the use of Lunit SCOPE IO, Lunit’s AI-powered pathology platform, for tumor microenvironment analysis in support of Summit’s immuno-oncology development programs with ivonescimab.

AWKO Law LLP is investigating a data breach that led to unauthorized access to the sensitive information of patients of Quest Diagnostics, a New Jersey-based diagnostic testing company.

The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving ServiceTitan, Inc. (NASDAQ: TTAN).

Delek Logistics Partners, LP (NYSE: DKL) (“Delek Logistics”) today declared its quarterly cash distribution for the third quarter 2026 of $1.14 per common limited partner unit, or $4.56 per common limited partner unit on an annualized basis. The third quarter 2026 cash distribution is payable on November 10, 2026, to unitholders of record on November 3, 2026.

AM Best has affirmed the Financial Strength Rating (FSR) of B++ (Good) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “bbb” (Good) of Redbridge Insurance Company Limited (RICL) (St. James, Barbados) and Redbridge Insurance Company (RIC) (Puerto Rico). The outlook of the FSR is stable while the outlooks for the Long-Term ICRs remain positive.

FICO (NYSE: FICO), global analytics software leader, today announced that it will hold its wholesale mortgage price for the FICO® Score through its tri-merge resellers at $10 for lenders and brokers enrolled in its Preferred Program. The $10 price is for a bundle of both the Classic FICO® Score, the credit score that has served as the industry standard for mortgage lending for nearly three decades, and the FICO® Score 10T, FICO’s modern credit score and the most predictive credit score available to the mortgage industry.

NIKE, Inc. (NYSE: NKE) plans to host an Investor Day on November 16–17, 2026. Due to limited capacity, in-person attendance is by invitation only. The main stage presentations on Tuesday, November 17, 2026, will be webcast live beginning at approximately 8:30 a.m. PT and are expected to conclude at approximately 12:00 p.m. PT at https://investors.nike.com/. A replay of the webcast and related materials will be available at the same location following the event.

Surf Air Mobility Inc. (NYSE: SRFM), a leading air mobility platform, today announced that it will release its third quarter 2026 financial results after market close on Thursday, November 5, 2026, and will host a webcast at 5:00 pm ET the same day.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Erasca, Inc. (“Erasca” or “the Company”) (NASDAQ: ERAS) for violations of the securities laws.

River City Bank (Nasdaq: RCBC) ("the Bank") reported net income of $30.6 million or $2.16 per share for the quarter ended September 30, 2026, which compares to $19.7 million, or $1.36 per share, for the same period in 2025. Net income was $68.2 million or $4.75 per share for the nine months ended September 30, 2026, which compares to $47.4 million, or $3.24 per share, for the nine months ended September 30, 2025. The Bank’s earnings for the quarter ended September 30, 2026 resulted in a 21.06% return on average equity and a 1.92% return on average assets. The Bank’s book value per share rose 14% to $42.32 as of September 30, 2026 from $37.04 per share as of September 30, 2025.

AMTD Digital Inc. (“AMTD Digital” or the “Company”, NYSE: HKD), a NYSE listed company and also a comprehensive digital solutions and global hospitality and VIP services platform headquartered in France, announces its unaudited financial results for the six months ended April 30, 2026.

Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced the launch of Chain Reaction, a global supply chain decarbonization program designed to help supply partners cut carbon emissions, optimize factory operations and unlock shared business growth. The initiative marks an expansion of Logitech’s climate strategy, providing direct operational support to help suppliers build their own decarbonization roadmaps while advancing Logitech’s science-based target to halve its Scope 3 greenhouse gas (GHG) emissions by 2030.

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will release financial results for the third quarter of 2026 after the market closes on Monday, November 9, 2026. Management will host a conference call that day to discuss third quarter 2026 financial and operating results at 4:30 p.m. Eastern Time.

The Board of Directors of Peoples Financial Services Corp. (“Peoples”) (NASDAQ: PFIS) declared a fourth quarter cash dividend of $0.6250 per share. The dividend is payable December 15, 2026 to shareholders of record November 30, 2026.

Stem, Inc. (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced that on October 19, 2026, it had notified the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with Section 802.01B of the NYSE Listed Company Manual (the “Manual”), which requires a listed company’s average global market capitalization over a consecutive 30 trading-day period to be not less than $50 million and, at the same time, its stockholders’ equity to be not less than $50 million. On October 20, 2026, the Company received a non-compliance letter from the NYSE confirming that the Company is not in compliance with the requirement of Section 802.01B of the Manual (the “NYSE Letter”).

Salesforce (NYSE: CRM), the #1 AI CRM, today announced it has granted equity awards under its 2014 Inducement Equity Incentive Plan (the "Plan") to new employees who joined Salesforce in connection with the acquisition of m3ter and Fin. The Plan was adopted by the Salesforce Board of Directors in July 2014, in accordance with New York Stock Exchange Rule 303A.08.

GondolaBio, a clinical-stage biopharmaceutical company developing novel medicines for patients living with genetic diseases, and the Children’s Tumor Foundation (CTF), NF’s global drug discovery engine focused on neurofibromatosis and schwannomatosis (collectively known as NF), today announced a partnership to advance GondolaBio’s preclinical neurofibromatosis type 1 (NF1) program.

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2026 financial results on Monday, November 9, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day.

The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Shares of Beneficial Interest — ticker symbol ELME —of Elme Communities (the “Company”) from the NYSE. Trading in the Company’s Shares of Beneficial Interest will be suspended immediately.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Roku, Inc. (“Roku” or “the Company”) (NASDAQ: ROKU) for potential breaches of fiduciary duty on the part of its directors and management.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Caesars Entertainment, Inc. (“Caesars” or “the Company”) (NASDAQ: CZR) for potential breaches of fiduciary duty on the part of its directors and management.

Wolters Kluwer Tax & Accounting today announced the launch of agentic tax return preparation in CCH Axcess™ Tax, further advancing CCH Axcess as the agentic platform for tax and accounting. Built into the cloud-native platform where firms already manage their tax work, agentic tax preparation helps firms reduce repetitive preparation work, increase capacity, and give tax professionals a stronger starting point for review.

Helix Innovations LLC, an operating company of Altria Group, Inc. (Altria) (NYSE: MO), today announced the winners of on!® nicotine pouches’ inaugural on!vitational, held October 16 and 17 at TGL’s SoFi Center in Palm Beach Gardens, Florida. The two-day golf and entertainment experience brought together eight teams of current and former professional athletes, golf personalities, entertainers and adult nicotine consumers age 25+ for a competition that combined golf, technology and entertainment.

The Federal Home Loan Bank of Chicago (FHLBank Chicago) today announced its preliminary and unaudited financial results for the third quarter of 2026.

Elucid Bioimaging Inc. (“Elucid”) today reaffirmed its commitment to advancing its mission – the prediction and personalization of the prevention of heart attack and stroke – and its confidence in the technology and intellectual property behind its products.

Liquid Strategies announced the launch of the Overlay Shares Nasdaq 100 Income ETF (OVQ), an actively managed ETF that combines Nasdaq-100 equity exposure with a put-spread options strategy designed to seek to generate income. This is the latest addition to Liquid Strategies’ longstanding experience managing option overlay strategies across the Overlay Shares ETF suite since 2019.

Infinity (Infinity Artificial Intelligence Institute), an automated AI research company building the software layer that makes any AI chip inference-ready, today announced two key hires to its engineering team. Aditya Om, a former senior software engineer at Meta Superintelligence Labs (MSL), joins Infinity as Staff Inference Optimization Engineer, and Elliot Arledge, whose CUDA and LLM coding courses have taught skills to more than two million people, joins as Member of Technical Staff.

PennyMac Mortgage Investment Trust (NYSE: PMT) will announce results for the quarter ended September 30, 2026, in a news release to be issued after the market close on Thursday, October 29, 2026. The conference call and live audio webcast is being rescheduled to 6:30 pm. Eastern Time from the originally scheduled 6:00 p.m. Eastern Time.

KBRA assigns preliminary ratings to five classes of notes issued by Foundation Finance Trust 2026-2 (“FFIN 2026-2”), an asset-backed securitization collateralized by unsecured consumer loans primarily used for home improvements.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below.

AM Best has affirmed the Financial Strength Rating (FSR) of B++ (Good) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “bbb+” (Good) of The Hand-in-Hand Mutual Fire Insurance Company Limited (HIHF) (Guyana). The outlook of the FSR is stable while the outlook of the Long-Term ICR is negative. Concurrently, AM Best has affirmed the FSR of B++ (Good) and the Long-Term ICR of “bbb” (Good) of Hand-in-Hand Mutual Life Assurance Company Limited (HIHL) (Guyana). The outlooks of these Credit Ratings (ratings) are negative. Both entities are collectively referred to as Hand-in-Hand Group.

PennyMac Financial Services, Inc. (NYSE: PFSI) will announce results for the quarter ended September 30, 2026, in a news release to be issued after the market close on Thursday, October 29, 2026. The conference call and live audio webcast is being rescheduled to 5:30 pm. Eastern Time from the originally scheduled 5:00 p.m. Eastern Time.

NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, today announced Anthony Palladino as Chief Financial Officer.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner Roche announced today late-breaking oral presentation data from the ongoing Phase 3 IMAgINATION study in adults with primary IgA nephropathy (IgAN) receiving optimized standard of care, demonstrating that investigational sefaxersen achieved a statistically significant and clinically meaningful 43.1% reduction in proteinuria (95% confidence interval [CI]: 32.5 - 52.0, P<0.0001), relative to placebo at 37 weeks, as measured by 24-hour urine protein-to-creatinine ratio (UPCR). Proteinuria is a key indicator of kidney damage and a reduction in UPCR is strongly associated with the preservation of long-term kidney function. Results presented at the American Society of Nephrology (ASN) Kidney Week 2026 also showed that, among patients with baseline hematuria (blood in urine), a greater proportion of patients achieved hematuria resolution at Week 37 with sefaxersen versus placebo.

The board of directors of Macy's, Inc. (NYSE: M) today declared a regular quarterly dividend of 19.15 cents per share on Macy's, Inc.’s common stock, payable on January 4, 2027, to shareholders of record at the close of business on December 15, 2026.

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today late-breaking oral presentation data from the ongoing Phase III IMAgINATION study in adults with primary IgA nephropathy (IgAN) receiving optimized standard of care, demonstrating that investigational sefaxersen achieved a statistically significant and clinically meaningful 43.1% reduction in proteinuria (95% confidence interval [CI]: 32.5 - 52.0, P<0.0001), relative to placebo at 37 weeks, as measured by 24-hour urine protein-to-creatinine ratio (UPCR). Proteinuria is a key indicator of kidney damage and a reduction in UPCR is strongly associated with the preservation of long-term kidney function. Results presented at the American Society of Nephrology (ASN) Kidney Week 2026 also showed that, among patients with baseline hematuria (blood in urine), a greater proportion of patients achieved hematuria resolution at Week 37 with sefaxersen versus placebo.

The Capital Corporation (“TCC”, www.thecapitalcorp.com) is pleased to announce that it served as the exclusive investment banking advisor to Champion Coach, Inc. (“Champion Coach” or the “Company”) in its partnership with Hoffmann Family of Companies (“HF Companies”).

Building on decades of holding pharmaceutical companies responsible for dangerous products and unlawful business practices, The Lanier Law Firm played a pivotal role supporting Texas Attorney General Ken Paxton in securing a $45 million settlement with Gilead Sciences, Inc. Announced on Oct. 22, the settlement resolves claims that the company offered illegal incentives to medical providers to prescribe its drugs over competitors’ medications.

Investors in Bank Of America Corporation ("Bank of America" or the "Company") (NYSE: BAC) have until December 15, 2026 to ask the Court to appoint them lead plaintiff in a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired Bank Of America Corporation securities between August 1, 2025 and October 13, 2026, inclusive. Glancy Prongay Wolke & Rotter LLP ("Glancy") today reminded investors of the upcoming deadline. The Bank Of America Corporation case, New England Teamsters Pension Fund v. Bank of America Corporation et al., was filed on October 16, 2026 and is pending in the U.S. District Court Southern District of New York (Case No. 1:26-cv-09137).

Lyntris Inc. (NYSE: LYNX), a defense technology company delivering integrated sensing, communications, and mission systems, today announced it will issue financial results for the third quarter fiscal year 2026 on Wednesday, November 4, 2026. Management will host a conference call and live audio webcast to discuss the results at 4:30 PM Eastern Time.

Robbins Geller Rudman & Dowd LLP announces that purchasers of Duolingo, Inc. (NASDAQ: DUOL) Class A common stock between May 2, 2025 and February 26, 2026, both dates inclusive (the “Class Period”), have until December 7, 2026 to seek appointment as lead plaintiff of the Duolingo class action lawsuit. Captioned City of Dearborn Heights Act 345 Police & Fire Retirement System v. Duolingo, Inc., No. 26-cv-02199 (W.D. Pa.), the Duolingo class action lawsuit charges Duolingo as well as certain of Duolingo’s current and former executive officers with violations of the Securities Exchange Act of 1934.

Millrose Properties, Inc. ("Millrose" or the "Company") (NYSE: MRP) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 8, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 7, 2025 through October 2, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Rubenstsein et al. v. Millrose Properties, Inc. et al., which was filed on October 9, 2026 in the U.S. District Court for the Southern District of Florida (Case No. 9:26-cv-81386).

KBRA assigns preliminary ratings to 96 classes of mortgage pass-through certificates from Chase Home Lending Mortgage Trust 2026-JINV2 (CHASE 2026-JINV2), a prime investor RMBS transaction comprising 327 residential mortgages with an aggregate interest-bearing principal balance of approximately $398.8 million as of the October 1, 2026 cut-off date. The underlying pool primarily consists of loans that are collateralized by investment properties (94.7%). The pool is characterized by substantial borrower equity in each mortgaged property, as evidenced by the WA original CLTV of 72.5%. The weighted average original credit score is 778, which is well within the prime mortgage range.

Palleon Pharmaceuticals, a clinical-stage biotechnology company developing glycan editing therapeutics for autoimmune disease and cancer, today announced Phase 2 results for HLX79/E-602 (efgitasialase alfa), a first-in-class sialidase-Fc fusion protein, in primary membranous nephropathy (pMN).

Pilot is proud to honor veterans and active-duty service members with a free meal on Veterans Day and invites guests to round up purchases to help veterans transition to civilian careers.

The Chemours Company ("Chemours" or the "Company") (NYSE: CC) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 7, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 20, 2026 through August 4, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Darcy v. The Chemours Company et al., which was filed on October 8, 2026 in the U.S. District Court District of Delaware (Wilmington) (Case No. 1:26-cv-01299).

Today, the Council for Citizens Against Government Waste (CCAGW) announced its endorsement of 12 candidates for the U.S. Senate, 123 candidates for the U.S. House of Representatives, and six candidates for governor. The candidates have been endorsed based on their lifetime rating in CCAGW’s 2025 Congressional Ratings.

Popular, Inc. (NASDAQ: BPOP) announced today that its Board of Directors has approved a quarterly cash dividend of $0.90 per share on its outstanding common stock. The dividend will be payable on January 4, 2027 to shareholders of record at the close of business on November 13, 2026.

Cirrus (Cirrus Aircraft Ltd.), the global leader in Personal Aviation™, broke ground on the 15,000-square-foot Engine Run-Up Center, designed to safely and efficiently test SR Series, Vision Jet®, and TRAC10 engine system functionality, performance, and fuel calibration as part of the aircraft certification process. Cirrus will invest over $8 million in the facility, which will provide a centralized, enclosed, well-equipped, climate-controlled building year-round. The Run-Up Center is expected to be completed and operational in summer 2027.

KBRA assigns preliminary ratings to five classes of notes issued by BHG Securitization Trust 2026-3CON (“BHG 2026-3CON”), an asset-backed securitization collateralized by a pool of unsecured consumer loans (“Consumer Loans”).

Antares today announced that the U.S. Department of Energy (DOE) has approved the Nuclear Safety Design Agreement (NSDA) for Mark-1, the company's first electricity-producing reactor. The approval is the first step in DOE's authorization pathway for Mark-1 and establishes the design requirements, safety analysis approach, and regulatory expectations that will govern the reactor through construction and operation.

Green Plains Inc. (NASDAQ:GPRE) will release third quarter 2026 financial results after the market closes on November 5, 2026, and then host a conference call beginning at 4:30 p.m. Eastern time (3:30 p.m. Central time) to discuss the results and outlook.

A securities class action lawsuit has been filed against D-Wave Quantum, Inc. ("D-Wave" or the "Company") (NASDAQ: QBTS) on behalf of investors who purchased or otherwise acquired D-Wave Quantum, Inc. securities from February 26, 2026 to August 25, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Fessler v. D-Wave Quantum, Inc. et al., filed on October 15, 2026 in the U.S. District Court California Northern District (Case No. 3:26-cv-11953). Lead plaintiff motions in the D-Wave Quantum, Inc. case are due by December 15, 2026.

Genmab A/S (Nasdaq: GMAB) announced today positive topline results from the global Phase 3 RAINFOL™-02 trial of rinatabart sesutecan (Rina-S®), an investigational folate receptor alpha (FRα)-targeted, topoisomerase I (TOPO1)-inhibitor antibody-drug conjugate (ADC), in patients with platinum-resistant ovarian cancer (PROC) regardless of FRα expression level or prior treatment with mirvetuximab. The trial met its primary endpoint of progression-free survival (PFS), with Rina-S demonstrating a statistically significant and clinically meaningful improvement compared with investigator’s choice chemotherapy in the intent-to-treat (ITT) and in the primary analysis set (PAS) populations.

AM Best has revised the outlooks to stable from negative and affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” (Excellent) of Medical Professional Mutual Insurance Company (Boston, MA) and its rating unit members, collectively known as Coverys Companies (Coverys). (See below for a detailed list of these subsidiaries and Credit Ratings [ratings]).

Western Alliance Bank hosted its first Western Alliance 100, an invitation-only CEO strategic forum in Phoenix that brought together top clients and business leaders from across the country to explore the forces shaping business decisions and the opportunities ahead. President George W. Bush joined Western Alliance Chairman, President and CEO Kenneth Vecchione for a moderated conversation, while Duke’s legendary Coach K and experts in markets, technology and demographic shifts also shared their viewpoints on key issues facing business leaders today.

Worthington Steel, Inc. (NYSE: WS) today announced that the proposed domination and profit and loss transfer agreement (“DPLTA”) between Kloeckner & Co SE (“Kloeckner”) and Worthington Steel GmbH, a wholly owned indirect subsidiary of Worthington Steel, did not receive the required shareholder approval at Kloeckner’s extraordinary general meeting in Düsseldorf, Germany. As a result, the DPLTA will not become effective. Worthington Steel remains committed to delivering on the long-term strategic and economic rationale of the transaction. For now, the company will operate within the existing ownership and governance structure and will pursue commercial, procurement, operational and strategic opportunities that can be advanced within that framework and in accordance with applicable law.

Hundreds of New Yorkers gathered at the Edison Ballroom on October 22, marking the 15th anniversary of Ronald McDonald House New York’s (RMH-NY) Board of Associates (BoA). The Annual Soirée brought together young professionals, alumni and supporters to celebrate the Board’s longstanding commitment to children and families facing pediatric cancer and other serious illnesses.

Mitsubishi Power Americas, Inc. today announced plans to expand its Savannah Machinery Works facility, a key U.S. manufacturing and service center for advanced-class gas turbines, steam turbines and power generation equipment serving customers across the Americas. The expanded facility will accelerate Mitsubishi Power’s ability to meet unprecedented power generation needs, with one location that combines advanced manufacturing, a skilled regional workforce and shipping, with port and rail access at the intersection of I-95 and I-16.

Customer platform Planhat today announced it has been recognized as a Leader in the 2026 Gartner® Magic Quadrant™ for Customer Success Management Platforms for the third consecutive year. The recognition follows a period of rapid innovation for Planhat, with the recent launch of Pi, the world’s first multiplayer customer agent. Pi works alongside entire account teams, drawing on shared context to run core commercial processes from sales and renewals to implementations and support.

Perfect Corp. (NYSE: PERF), a global leader in augmented reality (AR) and artificial intelligence (AI) beauty and fashion tech, today announced that YouCam is one of the first platforms to integrate the newly released Kling 4.0 API. The newest AI video model from Kuaishou Technology’s Kling AI is now live across the YouCam lineup on mobile and web. Built for longer storytelling, Kling 4.0 lets users set up to 10 keyframes instead of only a first and last frame, then generates up to 30 seconds of continuous video with lip-synced dialogue and stereo sound in a single pass.

AEG Presents, a global leader in live entertainment, announced today that Chris Hammond will take on the role of Senior Vice President of the Pacific Northwest. Hammond, most recently a VP of Talent at the promoter’s Las Vegas office, will now oversee booking and operational strategy for AEG Presents’ growing portfolio of Pacific Northwest venues. He will be based in Seattle and report to President of North American Regional Offices, Brent Fedrizzi.

Investors who lost money on Moderna, Inc. ("Moderna" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Moderna, Inc. (NASDAQ: MRNA) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 22, 2026 disclosure regarding Moderna, Inc.

Investors who lost money on FirstCash Holdings, Inc. ("FirstCash" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of FirstCash Holdings, Inc. (NASDAQ: FCFS) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 22, 2026 disclosure regarding FirstCash Holdings, Inc.

Investors who lost money on Integra LifeSciences Holdings Corporation ("Integra" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Integra LifeSciences Holdings Corporation (NASDAQ: IART) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 2, 2026 disclosure regarding Integra LifeSciences Holdings Corporation.

Investors who lost money on Carpenter Technology Corporation ("Carpenter Technology" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Carpenter Technology Corporation (NYSE: CRS) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 22, 2026 disclosure regarding Carpenter Technology Corporation.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced initial results from the Company’s Phase 1 study evaluating azercabtagene zapreleucel (azer-cel), an investigational, allogeneic CD19-directed chimeric antigen receptor (CAR) T-cell therapy, in patients with progressive multiple sclerosis (MS). The data represent the first reported clinical evaluation of an allogeneic CD19-directed CAR T-cell therapy in progressive MS and were presented in a late-breaking oral session at MSToronto2026, the 10th Joint Meeting of the Americas and European Committees for Treatment and Research in Multiple Sclerosis (ACTRIMS-ECTRIMS), being held October 21–23, 2026, in Toronto, Canada.

Dashen Bank and ShebaMiles have launched a Platinum co-branded Mastercard debit card in Ethiopia, combining secure payments, digital access, loyalty benefits and premium travel privileges in one offering.

Bristol Myers Squibb (NYSE: BMY) today announced disclosure of interim safety and efficacy results from the multiple sclerosis (MS) cohorts of the Phase 1, single-arm, dose-escalation Breakfree-2 study evaluating zolacabtagene autoleucel (zola-cel; BMS-986353), an investigational, autologous CD19-directed CAR T cell therapy, in patients with highly active relapsing MS (haRMS) and progressive forms of MS (PMS). The data are being presented today in an oral presentation (Abstract #1615) at MSToronto 2026, the 10th Joint ACTRIMS-ECTRIMS Meeting taking place in Toronto, Canada.